PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mosapramine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

19 hits

Bibliografisk träff 2017-05-11

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.

Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N.

Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/ndt.s134340

Bibliografisk träff 2015-02-20

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.

Kishi T, Matsuda Y, Matsunaga S, Iwata N.

Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/ndt.s78977

Bibliografisk träff 2014-12-10

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine.

Kishi T, Matsunaga S, Matsuda Y, Iwata N.

Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/ndt.s73464

Bibliografisk träff 2004-11-01

Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.

Oka T, Hamamura T, Lee Y, Miyata S, Habara T, Endo S, Taoka H, Kuroda S.

Life Sci · journal article · DOI 10.1016/j.lfs.2004.08.009

Bibliografisk träff 2001-01-01

Perospirone.

Onrust SV, McClellan K.

CNS Drugs · review; journal article · DOI 10.2165/00023210-200115040-00006

Bibliografisk träff 2000-10-01

The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.

Fujimura M, Hashimoto K, Yamagami K.

Life Sci · comparative study; journal article · DOI 10.1016/s0024-3205(00)00872-9

Bibliografisk träff 1999-01-01

Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia.

Takahashi N, Terao T, Oga T, Okada M.

Neuropsychobiology · clinical trial; randomized controlled trial; journal article · DOI 10.1159/000026565

Bibliografisk träff 1996-05-01

[The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].

Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T.

Nihon Yakurigaku Zasshi · comparative study; journal article; english abstract · DOI 10.1254/fpj.107.247

Bibliografisk träff 1995-11-01

[Quantitative autoradiographic analysis of the binding of mosapramine to dopamine D3-receptors].

Futamura T, Shimokawa T, Morio Y, Haga K, Fukuda T.

Nihon Yakurigaku Zasshi · comparative study; journal article; english abstract · DOI 10.1254/fpj.106.339

Bibliografisk träff 1995-02-01

Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy.

Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokogawa K.

Neuropsychopharmacology · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1038/sj.npp.1380239

Bibliografisk träff 1993-06-01

Syntheses and biological activities of optical isomers of 3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a]pyridine- 3-spiro-4'-piperidino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine (mosapramine) dihydrochloride.

Tashiro C, Setoguchi S, Fukuda T, Marubayashi N.

Chem Pharm Bull (Tokyo) · comparative study; journal article · DOI 10.1248/cpb.41.1074

Bibliografisk träff 1992-09-01

[Synthesis of metabolites of mosapramine. II. Synthesis of phenolic metabolites of mosapramine and their pharmacological activities].

Tashiro C, Yuasa S, Fukuda T.

Yakugaku Zasshi · journal article; english abstract · DOI 10.1248/yakushi1947.112.9_615

Bibliografisk träff 1992-03-01

[Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].

Uchihashi Y, Morimoto T, Tadokoro S.

Nihon Yakurigaku Zasshi · comparative study; journal article; english abstract · DOI 10.1254/fpj.99.153

Bibliografisk träff 1992-02-01

[Synthesis of metabolites of mosapramine. I. Synthesis of alcoholic metabolites].

Tashiro C, Yuasa S, Demizu K.

Yakugaku Zasshi · journal article; english abstract · DOI 10.1248/yakushi1947.112.2_108

Bibliografisk träff 1990-08-01

[Effect of Y-516 on the hyperactivity induced by dopamine injected bilaterally into the nucleus accumbens].

Morimoto T, Morimoto Y, Fukuda T, Setoguchi M.

Nihon Yakurigaku Zasshi · journal article; english abstract · DOI 10.1254/fpj.96.2_65

Bibliografisk träff 1989-01-01

Pharmacokinetic study of iminodibenzyl antipsychotic drugs, clocapramine and Y-516 in dog and man.

Ishigooka J, Murasaki M, Wakatabe H, Miura S, Hikida K, Shibata M, Nobunaga H.

Psychopharmacology (Berl) · comparative study; journal article · DOI 10.1007/bf00439442

Bibliografisk träff 1986-01-01

Pharmacological and biochemical properties of iminodibenzyl antipsychotic drugs including Y-516 and clocapramine.

Mikuni M, Yamashita I, Matsubara S, Odagaki Y, Setoguchi M, Fukuda T.

Clin Neuropharmacol · comparative study; journal article

Bibliografisk träff 1985-09-01

[Neuroleptic properties of Y-516, a new iminodibenzyl derivative].

Fukuda T, Setoguchi M, Morimoto Y, Shoji H, Tsumagari T, Maruyama Y.

Nihon Yakurigaku Zasshi · comparative study; journal article; english abstract · DOI 10.1254/fpj.86.197

Bibliografisk träff 1985-06-01

Effects of iminodibenzyl antipsychotic drugs on cerebral dopamine and alpha-adrenergic receptors.

Setoguchi M, Sakamori M, Takehara S, Fukuda T.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(85)90776-9